Optical coherence technology-angiography (OCTA) is a novel, non-invasive motion-contrast imaging technique used to generate volumetric angiography images quickly. This video concisely reviews interesting OCTA data presented this year’s ARVO congress, which was held in Seattle, US (Sunday 01 May 2016, 15:15–17:00 PM, Session 146). Overall, OCTA has been shown to precisely identify retinal vessels and capillary nonperfused areas in eyes with diabetic retinopathy. However, the biggest drawback when applying this technique is that OCTA cannot provide any insight or information on the retinal periphery area, which is particularly important when evaluating and managing diabetic patients.
Home / OCTA and diabetic retinopathy
OCTA and diabetic retinopathy
Other Perspective
Home monitoring
Paolo Lanzetta, MD, interviews Anat Loewenstein, MD, on home monitoring, a technology in which her r
High-dose Aflibercept: the PHOTON and PULSAR trials
Paolo Lanzetta, MD, and Jean-François Korobelnik, MD, PhD, speak about high-dose Aflibercept and th
What is the current situation of ophthalmology in Ukraine?
Paolo Lanzetta, MD interviews Andrii Korol, MD about the situation of ophthalmology in Ukraine.